Products

Valynce

AI-native

Building the Future of Wealth

valynce.org Finance / Investing & Trading

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$11.99/mo
Lower than 64% of peersNiche median $19/mo
Creators
Mary Wright
No social account linked
Launched
12mo ago
2025-11-26 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Building the Future of Wealth

    Nov 26, 2025 · 12mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-11-14

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free
$0
Portfolio tracking (10 holdings)
Premium
$11.99/mo
Unlimited holdings tracking
Pro
$21.99/mo
Unlimited auto-trading bots

Trial: None · 2 paid tiers ($11.99–$21.99) · Observed 2026-11-07 · Pricing page

Entry price $11.99/mo, Lower than 64% of peers; “Investing & Trading” median is $19/mo.View pricing benchmark

Website snapshots

Indexed 2025-11-26

Key pages

Desktop & mobile archive
valynce.org/ Snapshot 2026-11-07

Questions & evidence

How much does Valynce cost?
Free: $0; Premium: $11.99/mo; Pro: $21.99/mo. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Valynce get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Valynce and what platforms does it support?
Valynce is catalogued under Investing & Trading: Building the Future of Wealth. Supported platforms: Mobile App, API.

Related products in this category

Finance / Investing & Trading

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.